Travere Therapeutics(TVTX)
SAN DIEGO, CA
BiotechnologyFocus: Small Molecules, Biologics
Travere Therapeutics is a life sciences company focused on Small Molecules, Biologics.
NephrologyRare DiseasesNeurologyMetabolic DiseasesCardiovascular
Funding Stage
PUBLIC
Employees
201-500
Open Jobs
14
Products & Portfolio (1)
Pipeline & Clinical Trials
Natural History Study of Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (ACAPPELLA)
Homocystinuria Due to CBS DeficiencyClinical Trials (1)
NCT02998710Natural History Study of Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (ACAPPELLA)
N/ARare Group Problem Management Plus
AnxietyClinical Trials (1)
NCT06548022Rare Group Problem Management Plus
N/AHumanistic Burden of (FSGS) Focal Segmental Glomerulosclerosis and IgAN (Immunoglobulin A Nephropath
Focal Segmental GlomerulosclerosisClinical Trials (1)
NCT05200871Humanistic Burden of (FSGS) Focal Segmental Glomerulosclerosis and IgAN (Immunoglobulin A Nephropathy)
N/AConfirmatory Testing
Acid Sphingomyelinase DeficiencyCerebrotendinous Xanthomatosis (CTX) Prevalence Study
Cerebrotendinous Xanthomatosis (CTX)Clinical Trials (1)
NCT02638220Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
N/ARE-021, sparsentan
Healthy SubjectsClinical Trials (1)
NCT05562362Study to Evaluate the Pharmacokinetics of Oral Sparsentan Suspension
Phase 1sparsentan
Proteinuric Renal DiseaseClinical Trials (1)
NCT07224776Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria
Phase 1Pegtibatinase
HomocystinuriaClinical Trials (1)
NCT03406611Pegtibatinase As an Enzyme Therapy for Patients with Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (COMPOSE)
Phase 1/2Sparsentan
Focal Segmental GlomerulosclerosisClinical Trials (1)
NCT05003986Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Phase 2Phase 2
Clinical Trials (1)
NCT01613118Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis
Phase 2Sparsentan
ANCA Associated VasculitisClinical Trials (1)
NCT05630612ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)
Phase 2Sparsentan
Immunoglobulin A NephropathyClinical Trials (1)
NCT05856760A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN
Phase 2Sparsentan
Immunoglobulin A NephropathyClinical Trials (1)
NCT04663204A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy
Phase 2Pegtibatinase
HomocystinuriaClinical Trials (1)
NCT06431893A Phase 3 Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥5 to ≤65 Years of Age With Classical Homocystinuria (HCU) (ENSEMBLE)
Phase 3Fosmetpantotenate
Pantothenate Kinase-Associated NeurodegenerationClinical Trials (1)
NCT03041116Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Participants
Phase 3sparsentan
Focal Segmental GlomerulosclerosisClinical Trials (1)
NCT03493685Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS)
Phase 3Pegtibatinase
HomocystinuriaClinical Trials (1)
NCT06247085A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care Treatment
Phase 3sparsentan
Immunoglobulin A NephropathyClinical Trials (1)
NCT03762850A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
Phase 3Sparsentan
ProteinuriaClinical Trials (1)
NCT07219121Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis
Phase 4Open Jobs (14)
Sr. Clinical Nutrition Specialist
San Diego
23h ago
$95K - $124K/yr
Access & Reimbursement Manager (New Orleans, LA)
Remote
Yesterday
$162K - $211K/yr
Executive Director, Medical Monitor and Safety Physician
San Diego
5d ago
$285K - $385K/yr
Senior Manager, Pharmacometrics, Clinical Pharmacology
San Diego
5d ago
$132K - $172K/yr
Director, Scientific Engagement and Professional Societies
San Diego
Medical Affairs1w ago
$189K - $246K/yr
Senior Medical Director, Integrated Evidence Generation – Nephrology
San Diego
Medical Affairs2w ago
$233K - $315K/yr
Senior Medical Science Liaison - Northeast
Remote
Medical Affairs2w ago
$173K - $225K/yr
Director, Scientific Communications
San Diego
Medical Affairs2w ago
$189K - $246K/yr
Associate Director, Biostatistics
San Diego
Data Science & AI2w ago
$150K - $195K/yr
Senior Medical Science Liaison (Mid-Atlantic North)
Remote
3w ago
$173K - $225K/yr
Clinical Account Manager (Boston, MA)
Remote
Clinical Operations4w ago
$162K - $211K/yr
Senior Medical Science Liaison – Western US (Pegtibatinase)
Remote
Medical Affairs1mo ago
$173K - $225K/yr
Senior Manager, Regulatory Affairs Project Management
Rapperswil-Jona (SG), Switzerland
Regulatory Affairs1mo ago
Sr. Manager, Commercial CRM Solution Architect
San Diego
Commercial2mo ago
$132K - $172K/yr
Interview Prep Quick Facts
Portfolio: 1 approved product, 18 clinical trials
Top TAs: Nephrology, Cardiovascular, Immunology
SEC Filings: 2 available
Open Roles: 14 active jobs
Portfolio Health
Peak1 (100%)
1 total products
Therapeutic Area Focus
Marketed
Pipeline
Financials (FY2025)
Revenue
$145M33%
R&D Spend
$245M(169%)8%
Net Income
-$111MCash
$59MHiring Trend
Stable
14
Open Roles
+4
Added
-3
Filled/Removed
Based on last 4 crawl cycles